Dexmedetomidine for pediatric sedation for computed tomography imaging studies

Area of Science:

• Pediatric Sedation
• Radiological Imaging
• Pharmacology

Background:

• Dexmedetomidine is a sedative with limited documented use in pediatric populations.
• Pentobarbital was previously the standard for CT imaging sedation.
• A pilot program was initiated to evaluate dexmedetomidine for pediatric sedation.

Purpose of the Study:

• To prospectively evaluate the sedation profile of dexmedetomidine in pediatric patients.
• To assess the efficacy and safety of dexmedetomidine for sedation during radiological imaging.
• To compare dexmedetomidine's effects to pre-sedation baseline values.

Main Methods:

• A pilot program using intravenous dexmedetomidine was implemented for pediatric CT imaging sedation.
• Sixty-two pediatric patients received a 2 mcg/kg loading dose, followed by repeat boluses to achieve Ramsay Sedation Score 4.
• Patients were maintained on a 1 mcg/kg/hr infusion, with vital signs and recovery time monitored.

Main Results:

• Heart rate and mean arterial blood pressure decreased by approximately 15% during sedation and recovery (P < 0.01).
• No significant changes were observed in respiratory rate or end-tidal CO2.
• The average recovery time was 32 ± 18 minutes.

Conclusions:

• Dexmedetomidine provides a reliable and effective method for pediatric sedation during radiological imaging.
• The drug demonstrates a favorable safety profile with minimal impact on respiratory function.
• This pilot study supports the use of dexmedetomidine as a standard sedation protocol for pediatric imaging.